A citation-based method for searching scientific literature

Dong Seok Kim, Ho-Il Choi, Yun Wang, Yu Luo, Barry J Hoffer, Nigel H Greig. Cell Transplant 2017
Times Cited: 76

List of shared articles

Times cited

The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - a critical overview.
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner. Rev Neurosci 2022

The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders.
Jenq-Lin Yang, Wei-Yu Chen, Shang-Der Chen. Int J Mol Sci 2017

Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications.
Abdallah Hassan, Rajan Sharma Kandel, Rohi Mishra, Jeevan Gautam, Amer Alaref, Nusrat Jahan. Cureus 2020

Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Elena Alvarez-Rodriguez, Pablo Vicente-Alba, Javier Lago-Garma, Ana I Rodriguez-Perez. Neural Regen Res 2022

Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?
Qi Cheng, Jinluo Cheng, Dennis Cordato, Jianqun Gao. Pharmacol Ther 2020

Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.
Noha A Gouda, Ahmed Elkamhawy, Jungsook Cho. Biomedicines 2022

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021